Literature DB >> 12391519

Percutaneous radiofrequency ablation of nodal metastases.

Debra A Gervais1, Ronald S Arellano, Peter R Mueller.   

Abstract

We report our experience with percutaneous image-guided radiofrequency (RF) ablation to treat isolated nodal metastases. Four patients underwent image-guided percutaneous RF ablation of metastatic disease involving retrocrural nodes, retroperitoneal nodes, or pelvic nodes. Coagulation necrosis was achieved in all cases.

Entities:  

Mesh：

Year:  2002        PMID： 12391519     DOI： 10.1007/s00270-002-2661-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  5 in total

1.  Percutaneous ablation of lymph node metastases using CT-guided high-dose-rate brachytherapy.

Authors:  F Collettini; A C Schippers; D Schnapauff; T Denecke; B Hamm; H Riess; P Wust; B Gebauer
Journal:  Br J Radiol       Date:  2013-05-09       Impact factor: 3.039

Review 2.  Percutaneous radiofrequency ablation of renal cell carcinoma.

Authors:  Debra A Gervais; Ronald S Arellano; Peter R Mueller
Journal:  Eur Radiol       Date:  2005-03-09       Impact factor: 5.315

3.  Feasibility and safety of percutaneous computed tomography guided radiofrequency ablation of lymph nodes in oligometastatic patients: a single center's experience.

Authors:  Dimitrios Filippiadis; George Charalampopoulos; Athanasios Tsochatzis; Lazaros Reppas; Argyro Mazioti; Alexis Kelekis; Nikolaos Kelekis
Journal:  Br J Radiol       Date:  2021-03-23       Impact factor: 3.039

4.  A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer.

Authors:  Ru-Hai Zou; Qi-Jiong Li; Ji-Liang Qiu; Ya-Di Liao; Yun-Fei Yuan; An-Hua Li
Journal:  Chin J Cancer       Date:  2013-04-01

5.  Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space.

Authors:  Constanze Heinze; Jazan Omari; Matthias Manig; Peter Hass; Marino Venerito; Robert Damm; Tomasz Jargiełło; Jens Ricke; Maciej Powerski; Maciej Pech
Journal:  J Contemp Brachytherapy       Date:  2019-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.